Medicus Pharma Ltd. 是一家生物科技/生命科学公司,专注于在美国开发治疗性资产的临床开发项目。公司总部位于宾夕法尼亚州西康舍霍肯。
财务指标
营业收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
营业支出
2026-06-30
$829.16万
2026-03-31
$626.74万
2025-12-31
$779.06万
2025-09-30
$1542.63万
净利润
2026-06-30
-$839.19万
2026-03-31
-$659.18万
2025-12-31
-$818.44万
2025-09-30
-$1598.13万
净利润率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
每股收益
2026-06-30
$-0.21
2026-03-31
$-0.30
2025-12-31
$-0.44
2025-09-30
$-1.09
息税折旧摊销前利润
2026-06-30
-$829.16万
2026-03-31
-$696.67万
2025-12-31
-$798.89万
2025-09-30
-$1598.13万
有效税率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$0
$0
$0
$0
营业支出
$829.16万
$626.74万
$779.06万
$1542.63万
净利润
-$839.19万
-$659.18万
-$818.44万
-$1598.13万
净利润率
--
--
--
--
每股收益
$-0.21
$-0.30
$-0.44
$-1.09
息税折旧摊销前利润
-$829.16万
-$696.67万
-$798.89万
-$1598.13万
有效税率
--
--
--
--
常见问题
MDCX stock represents a publicly traded security on a U.S. exchange, offering investors exposure to a specific company's equity. The ticker MDCX identifies shares tied to the underlying business, which may operate in a niche sector. To fully understand MDCX, investors should review the company's profile, business model, and recent disclosures. The stock's price and trading activity reflect market sentiment and company-specific developments, so checking the latest MDCX data is essential for current information.
Recent performance for MDCX stock reflects its price movements over days, weeks, or months, which can be influenced by market trends and company news. Since performance data changes frequently, the most accurate recent performance figures are shown on the MDCX stock page. Investors often compare short-term moves against broader indices to gauge relative strength. For up-to-date performance, refer to the latest MDCX chart and statistics provided on this page.
Evaluating MDCX's valuation involves comparing its market price to fundamental metrics such as earnings, revenue, and book value. Common tools include the price-to-earnings (P/E) ratio, price-to-sales, and price-to-book, each offering a different perspective. Because valuation depends on current data, the specific metrics for MDCX are available on its stock detail page. Comparing these ratios to peers and industry averages can help determine if MDCX appears relatively expensive or inexpensive.
MDCX may be available for trading in pre-market and after-hours sessions, depending on the exchange and brokerage. These extended hours typically have lower liquidity and wider spreads than regular trading. Investors should confirm with their broker whether MDCX supports extended-hours trading and understand the associated risks. For specific session times, consult the trading information provided on the MDCX stock page, as availability can vary.
Key financial metrics for MDCX include revenue growth, net income, earnings per share, operating margin, and return on equity. These measures help assess profitability, efficiency, and financial health. Additionally, cash flow, debt levels, and free cash flow provide insight into liquidity and sustainability. Since these figures change with each reporting period, investors should review the latest MDCX financial statements and metrics displayed on the stock page for accurate, up-to-date analysis.
Investing in MDCX carries risks such as market volatility, sector-specific challenges, and company performance uncertainty. If MDCX operates in a competitive or cyclical industry, it may be more sensitive to economic shifts. Other risks include liquidity constraints, regulatory changes, and management execution. Investors should review MDCX's risk factors in its annual report and monitor news that could impact its business. The stock page may highlight relevant risk indicators.